No Data
Beijing Chieftain Control Engineering Technology (300430.SZ): The current products have not yet involved rehabilitation robots.
Gelonghui, on December 11, stated that Beijing Chieftain Control Engineering Technology (300430.SZ) indicated on the investor interaction platform that the company's existing products do not currently include rehabilitation robots. However, with continuous advancements in related technologies, the application of AI and robots will increasingly become prominent. The company has always paid close attention to the development of related technologies and will carefully consider suitable projects in the future to enhance the company's Business and continuously improve its core competitiveness.
Beijing Chieftain Control Engineering Technology (300430.SZ) plans to distribute a cash dividend of 0.25 yuan per 10 shares, with ex-rights and ex-dividends on November 8.
Announcement by Beijing Chieftain Control Engineering Technology (300430.SZ): The company's interim equity distribution plan for the first half of 2024 is proposed to distribute to all shareholders every 10...
Chengyitong: Report for the third quarter of 2024
Beijing Chieftain Control Engineering Technology (300430.SZ): Three brain-computer interface products are in the process of preparing for registration.
Beijing Chieftain Control Engineering Technology (300430.SZ) stated on the investor interactive platform on September 24 that the company's three brain-computer interface products are in the preparation stage for registration. They are preparing to apply for registration as Class II medical instruments. After submitting the registration, it will take approximately one to one and a half years to obtain certification. If there are specific substantive results and progress, the company will disclose strictly in accordance with relevant laws and regulations.
Beijing Chieftain Control Engineering Technology: Half-year report for the year 2024.
Beijing Chieftain Control Engineering Technology: Summary of Half-Year Report in 2024.
